Boston Scientific CorporationBSXNYSE
Loading

Analyst Sentiment

Analysts lean bullish — 96% recommend buying.

Consensus Rating
Buy
24 analysts·High coverage
96%
Rating Distribution
Strong Buy
14%
Buy
2292%
Hold
14%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 47% higher.

Bear Case
$94.00
+27%
Consensus
$108.35
+47%
Bull Case
$130.00
+76%
Price Range24 analysts
Low
Consensus
High
$94.00
$130.00
Current Target
Current Price
$73.85
Upside to Target
$34.50

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Feb 17, 2026Canaccord Genuity
Boston Scientific price target lowered to $109 from $112 at Canaccord
Target:$109.00
+45.9%from $74.73
Feb 6, 2026Bernstein
Boston Scientific price target lowered to $112 from $130 at Bernstein
Target:$112.00
+44.6%from $77.46
Feb 5, 2026Truist Financial
Boston Scientific price target lowered to $95 from $120 at Truist
Target:$95.00
+23.3%from $77.02
Feb 5, 2026RBC Capital
Boston Scientific price target lowered to $115 from $130 at RBC Capital
Target:$115.00
+49.0%from $77.17
Feb 5, 2026Needham
Boston Scientific price target lowered to $97 from $121 at Needham
Target:$97.00
+28.4%from $75.52
Feb 5, 2026Mizuho Securities
Boston Scientific price target lowered to $115 from $140 at Mizuho
Target:$115.00
+52.7%from $75.29
Feb 5, 2026Evercore ISI
Boston Scientific price target lowered to $96 from $112 at Evercore ISI
Target:$96.00
+26.9%from $75.64
Feb 5, 2026Wells Fargo
Boston Scientific price target lowered to $94 from $125 at Wells Fargo
Target:$94.00
+24.5%from $75.50
Feb 5, 2026Goldman Sachs
Boston Scientific price target lowered to $99 from $112 at Goldman Sachs
Target:$99.00
+31.1%from $75.50
Feb 5, 2026Robert W. Baird
Boston Scientific price target lowered to $101 from $118 at Baird
Target:$101.00
+33.8%from $75.50
Feb 5, 2026UBS
Boston Scientific price target lowered to $120 from $140 at UBS
Target:$120.00
+58.9%from $75.50
Feb 5, 2026Canaccord Genuity
Boston Scientific price target lowered to $112 from $131 at Canaccord
Target:$112.00
+48.3%from $75.50
Feb 4, 2026Stifel Nicolaus
Boston Scientific (BSX) PT Lowered to $110 at Stifel
Target:$110.00
+45.7%from $75.50
Feb 4, 2026BTIG
Boston Scientific price target lowered to $110 from $132 at BTIG
Target:$110.00
+45.5%from $75.61
Feb 3, 2026Barclays
Boston Scientific price target lowered to $124 from $136 at Barclays
Target:$124.00
+35.0%from $91.87
Feb 2, 2026National Bank
TD Cowen Reiterates Buy Rating on Boston Scientific (BSX)
Target:$115.00
+23.5%from $93.13
Jan 16, 2026Oppenheimer
Boston Scientific price target lowered to $100 from $125 at Oppenheimer
Target:$100.00
+11.1%from $90.03
Jan 9, 2026Goldman Sachs
Boston Scientific price target lowered to $112 from $124 at Goldman Sachs
Target:$112.00
+13.8%from $98.38
Jan 5, 2026Evercore ISI
Boston Scientific price target lowered to $112 from $113 at Evercore ISI
Target:$112.00
+17.7%from $95.15
Dec 18, 2025Truist Financial
Boston Scientific price target lowered to $120 from $130 at Truist
Target:$120.00
+24.3%from $96.56
Dec 17, 2025RBC Capital
Boston Scientific price target raised to $130 from $125 at RBC Capital
Target:$130.00
+39.9%from $92.95
Dec 17, 2025Canaccord Genuity
Boston Scientific price target lowered to $131 from $132 at Canaccord
Target:$131.00
+40.9%from $92.95
Oct 23, 2025Truist Financial
Boston Scientific price target raised to $130 from $129 at Truist
Target:$130.00
+25.6%from $103.53
Oct 23, 2025Morgan Stanley
Boston Scientific price target raised to $130 from $125 at Morgan Stanley
Target:$130.00
+25.2%from $103.85
Oct 23, 2025UBS
Boston Scientific price target raised to $140 from $135 at UBS
Target:$140.00
+34.3%from $104.23